How big pharma blocks access to low-cost generic drugs
Discover how big pharma's 'pay for delay' schemes keep affordable generics out of reach, driving up prescription costs and impacting health care.
Explore key trends, perspectives and policy advocacy on vital issues affecting health care.
Discover how big pharma's 'pay for delay' schemes keep affordable generics out of reach, driving up prescription costs and impacting health care.
Learn more about recent health care news and insights.
Subscribe to stay in the know on health care industry news and insights.